Clinical modalities and therapeutic outcomes; Observational cohort comparison between ever-smokers versus never-smokers of tuberculosis patients in Penang, Malaysia.

Year 2010, Volume: 7 Issue: 4, 389 - 397, 01.12.2010

Syed Wasif Gillani Syed Azhar Syed Sulaiman Juman Abdulelah Ali

https://izlik.org/JA36FJ53UB

Abstract

Keywords

-

Clinical modalities and therapeutic outcomes; Observational cohort comparison between ever-smokers versus never-smokers of tuberculosis patients in Penang, Malaysia.

https://izlik.org/JA36FJ53UB

Abstract

-

Keywords

-

References

• Davies P O, Yew W, Ganguly D, Davidow A L, Reichman L B, Dheda K, Rook G A. Smoking and tuberculosis: the epi- demiological association and immunopathogenesis. Trans R Soc Trop Med Hyg 2006;100:291-8.
• Hassmiller K. The association between smoking and tu- berculosis. Salud Pşblica de México 2006;(48):201-16.
• Bates M, Khalakdina A, Pai M, Chang L, Lessa F, Smith K. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med, 2007;167:335-41
• Lin H, Ezzati M, MurrayM. Tobacco smoke, indoor air pol- lution and tuberculosis: a systematic review and meta- analysis. PLoS Medicine 2007;(4):173-7
• Bruce N, Perez-Padilla R, Albalak R. Indoor air pollu- tion in developing countries: a major environmental and public health challenge. Bulletin of the World Health Organization 2000;78:1078-92.
• Wiklinson L. Sir Austin Bradford Hill: medical statistics and the quantitative approach to prevention of disease. Addiction 2000;92:657-66.
• Reichler M, Reves R, Bur S, et al. Evaluation of investi- gations conducted to detect and prevent transmission of tuberculosis. Am Med Assoc 2002;287(22):2944-49
• Frieden T, Fujiwara P, Washko R, Hamburg M. Tuberculosis in New York City-turning the tide. N Engl J Med 1995;333:229–33.
• Pio A, Chaulet P. Tuberculosis handbook. WHO/TB/98.253, Geneva, 1998
• Burman W, Dalton C, Cohn D, Butler J, Rever R. A cost- effectiveness analysis of directly observed therapy vs self-administered therapy for treatment of tuberculosis. Chest 1997;112:63-70.
• Ministry of Health Malaysia, Clinical Practice Guidelines On Treatement of tobacco use and dependence. (2002)
• Centers for disease control and prevention, National Center for Health Statistics. (2008)
• Leung C, Yew W, Chan C, Tam C, Lam C, Chang K, Chau C, Lau K, Law W. Smoking and tuberculosis in Hong Kong. Int J Tuberc Lung Dis 2003;7:980-6.
• Abal A, Jayakrishnan B, Parwer S, El Shamy A, Abahussain E, Sharma N, Effect of cigarette smoking on sputum smear conversion in adults with active pulmonary tuberculosis. Respiratory Medicine 2005;99:415-20.
• Santha T, Garg R, et al. Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis, 2002;6:780-8
• Dye C, Garnett G, Sleeman K, Williams B. Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Lancet 1998;352:1886-91.
• Hopewell P, Pai M, Maher D, Uplekar M, Raviglione M. International standards for tuberculosis care. Lancet Infect Dis 2006;6:710-25.
• Migliori G, Hopewell P, Blasi F, Spanevello A, Raviglione M. Improving the TB case management: the International Standards for Tuberculosis care. Eur Respir J 2006;28:687-90.
• Fair E, Hopewell P, Pai M. International Standards for Tuberculosis Care: revisiting the cornerstones of tuber- culosis care and control. Expert Rev Anti Infect Ther 2007;5:61-5.
• Faustini A, Hall A, Perucci C. Tuberculosis treatment out- comes in Europe: a systematic review. Eur Respir J 2005; (26):503-10.
• Nelson R. WHO's tuberculosis control strategy said to be insufficient. Lancet Infect Dis 2004;(4):653-8.
• Mccarthy M. Experts see progress in fight against tubercu- losis. The Lancet 2002;(359):2005-6.
• Oblast I. Tuberculosis Treatment Interruptions—Ivanovo Oblast, Russian Federation, 1999. World, 50.
• Chang K., Leung C, Tam C. Risk factors for defaulting from anti-tuberculosis treatment under directly observed treatment in Hong Kong. Int J Tuberc Lung Dis 2004;(8): 1492-8.
• Shamaei M, Marjani M, Chitsaz E, et al. First-line anti- tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveil- lance. Int J Tuberc Lung Dis 2009;13(5):236-40.
• Gajalakshmi V, Peto R, Kanaka T, Jha P. Smoking and mor- tality from tuberculosis and other diseases in India: ret- rospective study of 43 000 adult male deaths and 35 000 controls. The Lancet 2003;(362):507-15.
• Doll R, Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. BMJ 1976;(2):1525- 36
• Altel-Gomez M, Alcaide J, Godoy P, Romero M, Hernandez Del I. Clinical and epidemiological aspects of smoking and tuberculosis: a study of 13 038 cases. Int J Tuberc Lung Dis 2005;(9):430-6.
• Yach D. Partnering for better lung health: improving tobacco and tuberculosis control. Int J Tuberc Lung Dis 2000;(4):693-7.
• Mauray V, Vijayan V, Shah A. Smoking and tuberculosis: an association overlooked. Int J Tuberc Lung Dis: the official journal of the International Union against Tuberculosis and Lung Disease 2002;(6):942-51.
• Pai M, Mohan A, Dheda K, et al. Lethal interaction: the colliding epidemics of tobacco and tuberculosis. Expert Rev Anti Infect Ther 2007;(5):385-91.